Autoimmunity in Wiskott–Aldrich Syndrome: Updated Perspectives

References

• Wiskott A. Familiarer, angeborener morbus werlhofii? Monatsschr Kinderheilkd. 1937;68:212–216.
   Google Scholar
• Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 1954;13:133–139.
   PubMed Web of Science ®Google Scholar
• Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117(4):725–738. doi:10.1016/j.jaci.2006.02.005
   PubMed Web of Science ®Google Scholar
• Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15(1):84–90. doi:10.1016/j.bbmt.2008.10.007
   Web of Science ®Google Scholar
• Notarangelo LD, Miao CH, Ochs HD. Wiskott-Aldrich syndrome. Curr Opin Hematol. 2008;15(1):30–36. doi:10.1097/MOH.0b013e3282f30448
   Web of Science ®Google Scholar
• Perry GS 3rd, Spector BD, Schuman LM, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr. 1980;97(1):72–78. doi:10.1016/s0022-3476(80)80133-8
   PubMed Web of Science ®Google Scholar
• Fasth A. Primary immunodeficiency disorders in Sweden: cases among children, 1974–1979. J Clin Immunol. 1982;2(2):86–92. doi:10.1007/BF00916891
   PubMed Web of Science ®Google Scholar
• Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J Clin Immunol. 1988;8(6):479–485. doi:10.1007/BF00916954
   Web of Science ®Google Scholar
• Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78(4):635–644. doi:10.1016/0092-8674(94)90528-2
   PubMed Web of Science ®Google Scholar
• Kwan SP, Lehner T, Hagemann T, et al. Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22-Xp11.3. Genomics. 1991;10(1):29–33. doi:10.1016/0888-7543(91)90480-3
   Web of Science ®Google Scholar
• Rivero-Lezcano OM, Marcilla A, Sameshima JH, Robbins KC. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol Cell Biol. 1995;15(10):5725–5731. doi:10.1128/mcb.15.10.5725
   PubMed Web of Science ®Google Scholar
• Symons M, Derry JM, Karlak B, et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 1996;84(5):723–734. doi:10.1016/s0092-8674(00)81050-8
   Web of Science ®Google Scholar
• Miki H, Nonoyama S, Zhu Q, Aruffo A, Ochs HD, Takenawa T. Tyrosine kinase signaling regulates Wiskott-Aldrich syndrome protein function, which is essential for megakaryocyte differentiation. Cell Growth Differ. 1997;8:195–202.
   Google Scholar
• Miki H, Takenawa T. Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization. Biochem Biophys Res Commun. 1998;243(1):73–78. doi:10.1006/bbrc.1997.8064
   Web of Science ®Google Scholar
• Parolini O, Berardelli S, Riedl E, et al. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. Blood. 1997;1(90):70–75. doi:10.1182/blood.V90.1.70
   Google Scholar
• Cory GO, MacCarthy-Morrogh L, Banin S, et al. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J Immunol. 1996;157:3791–3795.
   Web of Science ®Google Scholar
• Gallego MD, Santamaría M, Peña J, Molina IJ. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood. 1997;90(8):3089–3097. doi:10.1182/blood.V90.8.3089
   Web of Science ®Google Scholar
• Krawczyk C, Bachmaier K, Sasaki T, et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity. 2000;13(4):463–473. doi:10.1016/s1074-7613(00)00046-7
   Web of Science ®Google Scholar
• Sasahara Y, Rachid R, Byrne MJ, et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell. 2002;10(6):1269–1281. doi:10.1016/s1097-2765(02)00728-1
   Web of Science ®Google Scholar
• Dupré L, Aiuti A, Trifari S, et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity. 2002;17(2):157–166. doi:10.1016/s1074-7613(02)00360-6
   Web of Science ®Google Scholar
• Linder S, Higgs H, Hüfner K, Schwarz K, Pannicke U, Aepfelbacher M. The polarization defect of Wiskott-Aldrich syndrome macrophages is linked to dislocalization of the Arp2/3 complex. J Immunol. 2000;165(1):221–225. doi:10.4049/jimmunol.165.1.221
   PubMed Web of Science ®Google Scholar
• Jones GE, Zicha D, Dunn GA, Blundell M, Thrasher A. Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp. Int J Biochem Cell Biol. 2002;34(7):806–815. doi:10.1016/s1357-2725(01)00162-5
   Web of Science ®Google Scholar
• Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet. 2001;27(3):313–317. doi:10.1038/85886
   PubMed Web of Science ®Google Scholar
• Ancliff PJ, Blundell MP, Cory GO, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood. 2006;108(7):2182–2189. doi:10.1182/blood-2006-01-010249
   Web of Science ®Google Scholar
• Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125(6):876–885. doi:10.1016/s0022-3476(05)82002-5
   PubMed Web of Science ®Google Scholar
• Ozsahin H, Le Deist F, Benkerrou M, et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr. 1996;129(2):238–244. doi:10.1016/s0022-3476(96)70248-2
   Web of Science ®Google Scholar
• Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980–2009: an International Collaborative Study. Blood. 2011;118(6):1675–1684. doi:10.1182/blood-2010-11-319376
   PubMed Web of Science ®Google Scholar
• Shin CR, Kim MO, Li D, et al. Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome. Bone Marrow Transplant. 2012;47(11):1428–1435. doi:10.1038/bmt.2012.31
   PubMed Web of Science ®Google Scholar
• Chen N, Zhang ZY, Liu DW, Liu W, Tang XM, Zhao XD. The clinical features of autoimmunity in 53 patients with Wiskott-Aldrich syndrome in China: a Single-Center Study. Eur J Pediatr. 2015;174(10):1311–1318. doi:10.1007/s00431-015-2527-3
   Web of Science ®Google Scholar
• Burroughs LM, Petrovic A, Brazauskas R, et al. Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood. 2020;135(23):2094–2105. doi:10.1182/blood.2019002939
   PubMed Web of Science ®Google Scholar
• Catucci M, Castiello MC, Pala F, Bosticardo M, Villa A. Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol. 2012;3:209. doi:10.3389/fimmu.2012.00209
   PubMed Web of Science ®Google Scholar
• Gershwin ME, Blaese RM, Steinberg AD, Wistar R Jr, Strober W. Antibodies to nucleic acids in congenital immune deficiency states. J Pediatr. 1976;89(3):377–381. doi:10.1016/s0022-3476(76)80531-8
   Web of Science ®Google Scholar
• Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111(5):e622–7. doi:10.1542/peds.111.5.e622
   Web of Science ®Google Scholar
• Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103(2):456–464. Epub 2003 Sep 11. PMID: 12969986. doi:10.1182/blood-2003-05-1480
   PubMed Web of Science ®Google Scholar
• Lee PP, Chen TX, Jiang L-P, et al. Clinical and molecular characteristics of 35 Chinese children with Wiskott-Aldrich syndrome. J Clin Immunol. 2009;29(4):490–500. doi:10.1007/s10875-009-9285-9
   Google Scholar
• Albert MH, Bittner TC, Nonoyama S, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood. 2010;115(16):3231–3238. doi:10.1182/blood-2009-09-239087
   PubMed Web of Science ®Google Scholar
• Elfeky RA, Furtado-Silva JM, Chiesa R, et al. One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years. J Allergy Clin Immunol. 2018;142(5):1654–1656.e7. doi:10.1016/j.jaci.2018.06.042
   PubMed Web of Science ®Google Scholar
• Jin YY, Wu J, Chen TX, Chen J. When WAS gene diagnosis is needed: seeking clues through comparison between patients with wiskott-aldrich syndrome and idiopathic thrombocytopenic purpura? Front Immunol. 2019;10:1549. doi:10.3389/fimmu.2019.01549
   PubMed Web of Science ®Google Scholar
• Haskoloğlu Ş, Öztürk A, Öztürk G, et al. Clinical features and outcomes of 23 patients with Wiskott-Aldrich syndrome: a single-center experience. Turk J Haematol. 2020;37(4):271–281. doi:10.4274/tjh.galenos.2020.2020.0334
   Web of Science ®Google Scholar
• Suri D, Rikhi R, Jindal AK, et al. Wiskott Aldrich syndrome: a multi-institutional experience from India. Front Immunol. 2021;12:627651. doi:10.3389/fimmu.2021.627651
   PubMed Web of Science ®Google Scholar
• Malinova D, Fritzsche M, Nowosad CR, et al. WASp-dependent actin cytoskeleton stability at the dendritic cell immunological synapse is required for extensive, functional T cell contacts. J Leukoc Biol. 2016;99(5):699–710. doi:10.1189/jlb.2A0215-050RR
   PubMed Web of Science ®Google Scholar
• Bouma G, Mendoza-Naranjo A, Blundell MP, et al. Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming. Blood. 2011;118(9):2492–2501. doi:10.1182/blood-2011-03-340265
   Web of Science ®Google Scholar
• Stabile H, Carlino C, Mazza C, et al. Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state. Blood. 2010;115(14):2818–2826. doi:10.1182/blood-2009-07-235804
   Web of Science ®Google Scholar
• Maillard MH, Cotta-de-almeida V, Takeshima F, et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells. J Exp Med. 2007;204(2):381–391. doi:10.1084/jem.20061338
   Web of Science ®Google Scholar
• Westerberg L, Larsson M, Hardy SJ, Fernández C, Thrasher AJ, Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2005;105(3):1144–1152. doi:10.1182/blood-2004-03-1003
   PubMed Web of Science ®Google Scholar
• Molina IJ, Kenney DM, Rosen FS, Remold-O’Donnell E. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med. 1992;176(3):867–874. doi:10.1084/jem.176.3.867
   Web of Science ®Google Scholar
• Rivers E, Thrasher AJ. Wiskott-Aldrich syndrome protein: emerging mechanisms in immunity. Eur J Immunol. 2017;47(11):1857–1866. doi:10.1002/eji.201646715
   Web of Science ®Google Scholar
• Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci. 2013;1285(1):26–43. doi:10.1111/nyas.12049
   Web of Science ®Google Scholar
• Marangoni F, Bosticardo M, Charrier S, et al. Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models. Mol Ther. 2009;17(6):1073–1082. doi:10.1038/mt.2009.31
   PubMed Web of Science ®Google Scholar
• Golding B, Muchmore AV, Blaese RM. Newborn and Wiskott-Aldrich patient B cells can be activated by TNP-Brucella abortus: evidence that TNP-Brucella abortus behaves as a T-independent type 1 antigen in humans. J Immunol. 1984;133:2966–2971. PMID: 6436369.
   Web of Science ®Google Scholar
• Meyer-Bahlburg A, Becker-Herman S, Humblet-Baron S, et al. Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood. 2008;112(10):4158–4169. doi:10.1182/blood-2008-02-140814
   Web of Science ®Google Scholar
• Erdei A, Isaák A, Török K, et al. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. Mol Immunol. 2009;46(14):2767–2773. doi:10.1016/j.molimm.2009.05.181
   Web of Science ®Google Scholar
• Recher M, Burns SO, de la Fuente MA, et al. B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice. Blood. 2012;119(12):2819–2828. doi:10.1182/blood-2011-09-379412
   Web of Science ®Google Scholar
• Castiello MC, Bosticardo M, Pala F, et al. Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans. J Autoimmun. 2014;50:42–50. doi:10.1016/j.jaut.2013.10.006
   PubMed Web of Science ®Google Scholar
• Kolhatkar NS, Scharping NE, Sullivan JM, et al. B-cell intrinsic TLR7 signals promote depletion of the marginal zone in a murine model of Wiskott-Aldrich syndrome. Eur J Immunol. 2015;45(10):2773–2779. doi:10.1002/eji.201545644
   Web of Science ®Google Scholar
• Simon KL, Anderson SM, Garabedian EK, Moratto D, Sokolic RA, Candotti F. Molecular and phenotypic abnormalities of B lymphocytes in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2014;133(3):896–9.e4. doi:10.1016/j.jaci.2013.08.050
   Web of Science ®Google Scholar
• Bouma G, Carter NA, Recher M, et al. Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cells. Eur J Immunol. 2014;44(9):2692–2702. doi:10.1002/eji.201344245
   Web of Science ®Google Scholar
• Mars LT, Araujo L, Kerschen P, et al. Invariant NKT cells inhibit development of the Th17 lineage. Proc Natl Acad Sci U S A. 2009;106(15):6238–6243. Epub 2009. doi:10.1073/pnas.0809317106
   Web of Science ®Google Scholar
• Yang JQ, Wen X, Kim PJ, Singh RR. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner. J Immunol. 2011;186(3):1512–1520. doi:10.4049/jimmunol.1002373
   Web of Science ®Google Scholar
• Astrakhan A, Ochs HD, Rawlings DJ. Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J Immunol. 2009;182(12):7370–7380. doi:10.4049/jimmunol.0804256
   Web of Science ®Google Scholar
• Locci M, Draghici E, Marangoni F, et al. The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J Exp Med. 2009;206(4):735–742. Epub 2009 Mar 23. doi:10.1084/jem.20081773
   Web of Science ®Google Scholar
• Rönnblom L. The type I interferon system in the etiopathogenesis of autoimmune diseases. Ups J Med Sci. 2011;116(4):227–237. doi:10.3109/03009734.2011.624649
   PubMed Web of Science ®Google Scholar
• Prete F, Catucci M, Labrada M, et al. Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells. J Exp Med. 2013;210(2):355–374. doi:10.1084/jem.20120363
   Web of Science ®Google Scholar
• Nikolov NP, Shimizu M, Cleland S, et al. Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein. Blood. 2010;116(5):740–747. doi:10.1182/blood-2009-08-237560
   Web of Science ®Google Scholar
• Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356(6367):314–317. doi:10.1038/356314a0
   PubMed Web of Science ®Google Scholar
• Sobel ES, Kakkanaiah VN, Cohen PL, Eisenberg RA. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int Immunol. 1993;5(10):1275–1278. doi:10.1093/intimm/5.10.1275
   Web of Science ®Google Scholar
• Lee PP, Lobato-Márquez D, Pramanik N, et al. Wiskott-Aldrich syndrome protein regulates autophagy and inflammasome activity in innate immune cells. Nat Commun. 2017;8(1):1576. PMID: 29146903; PMCID: PMC5691069. doi:10.1038/s41467-017-01676-0
   Web of Science ®Google Scholar
• Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104(13):4010–4019. doi:10.1182/blood-2003-05-1592
   PubMed Web of Science ®Google Scholar
• Lee WI, Huang JL, Jaing TH, Wu KH, Chien YH, Chang KW. Clinical aspects and genetic analysis of taiwanese patients with wiskott-Aldrich syndrome protein mutation: the first identification of x-linked thrombocytopenia in the chinese with novel mutations. J Clin Immunol. 2010;30(4):593–601. doi:10.1007/s10875-010-9381-x
   Web of Science ®Google Scholar
• Ferrua F, Cicalese MP, Galimberti S, et al. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, Phase 1/2 clinical study. Lancet Haematol. 2019;6(5):e239–e253. doi:10.1016/S2352-3026(19)30021-3
   PubMed Web of Science ®Google Scholar
• Braun CJ, Boztug K, Paruzynski A, et al. Gene therapy for Wiskott-Aldrich syndrome–long-term efficacy and genotoxicity. Sci Transl Med. 2014;6(227):227ra33. doi:10.1126/scitranslmed.3007280
   PubMed Web of Science ®Google Scholar
• Kolluri R, Shehabeldin A, Peacocke M, et al. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum Mol Genet. 1995;4(7):1119–1126. doi:10.1093/hmg/4.7.1119
   Web of Science ®Google Scholar
• Vignesh P, Suri D, Rawat A, et al. Sclerosing cholangitis and intracranial lymphoma in a child with classical Wiskott-Aldrich syndrome. Pediatr Blood Cancer. 2017;64(1):106–109. doi:10.1002/pbc.26196
   Web of Science ®Google Scholar
• Xie JW, Zhang ZY, Wu JF, et al. In vivo reversion of an inherited mutation in a Chinese patient with Wiskott-Aldrich syndrome. Hum Immunol. 2015;76(6):406–413. doi:10.1016/j.humimm.2015.04.001
   Web of Science ®Google Scholar
• Wu J, Liu D, Tu W, Song W, Zhao X. T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;135(1):209–216. doi:10.1016/j.jaci.2014.06.025
   Web of Science ®Google Scholar
• Liu DW, Zhang ZY, Zhao Q, et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: clinical characteristic and genotype-phenotype correlation. Pediatr Blood Cancer. 2015;62(9):1601–1608. doi:10.1002/pbc.25559
   PubMed Web of Science ®Google Scholar
• Boztug K, Schmidt M, Schwarzer A, et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med. 2010;363(20):1918–1927. doi:10.1056/NEJMoa1003548
   PubMed Web of Science ®Google Scholar
• Hacein-Bey Abina S, Gaspar HB, Blondeau J, et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA. 2015;313(15):1550–1563. doi:10.1001/jama.2015.3253
   PubMed Web of Science ®Google Scholar
• Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55–66. doi:10.2147/TACG.S58444
   Google Scholar
• Pala F, Morbach H, Castiello MC, et al. Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients. J Clin Invest. 2015;125(10):3941–3951. doi:10.1172/JCI82249
   Web of Science ®Google Scholar
• Amarinthnukrowh P, Ittiporn S, Tongkobpetch S, et al. Clinical and molecular characterization of Thai patients with Wiskott-Aldrich syndrome. Scand J Immunol. 2013;77(1):69–74. doi:10.1111/sji.12004
   Web of Science ®Google Scholar
• Schindelhauer D, Weiss M, Hellebrand H, et al. Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet. 1996;98(1):68–76. doi:10.1007/s004390050162
   Web of Science ®Google Scholar
• Knight T, Kotz K, Savaşan S. Autoimmune thyroiditis following HLA-matched sibling hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome. Pediatr Transplant. 2018;22(5):e13222. doi:10.1111/petr.13222
   Web of Science ®Google Scholar
• Kolhatkar NS, Brahmandam A, Thouvenel CD, et al. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome. J Exp Med. 2015;212(10):1663–1677. doi:10.1084/jem.20150585
   PubMed Web of Science ®Google Scholar
• Marangoni F, Trifari S, Scaramuzza S, et al. WASP regulates suppressor activity of human and murine CD4(+) CD25(+) FOXP3(+) natural regulatory T cells. J Exp Med. 2007;204(2):369–380. doi:10.1084/jem.20061334
   PubMed Web of Science ®Google Scholar
• Glanzmann B, Möller M, Schoeman M, et al. Identification of a novel WAS mutation in a South African patient presenting with atypical Wiskott-Aldrich syndrome: a case report. BMC Med Genet. 2020;21(1):124. doi:10.1186/s12881-020-01054-6
   Web of Science ®Google Scholar
• Shigemura T, Nakazawa Y, Shimojo H, Kobayashi N, Agematsu K. Immune complex-mediated glomerulonephritis in a patient with Wiskott-Aldrich syndrome. J Clin Immunol. 2016;36(4):357–359. doi:10.1007/s10875-016-0258-5
   Web of Science ®Google Scholar
• Trifari S, Sitia G, Aiuti A, et al. Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from wiskott-aldrich syndrome patients. J Immunol. 2006;177(10):7451–7461. doi:10.4049/jimmunol.177.10.7451
   Web of Science ®Google Scholar
• Du HQ, Zhang X, An YF, Ding Y, Zhao XD. Effects of Wiskott-Aldrich syndrome protein deficiency on IL-10-producing regulatory B cells in humans and mice. Scand J Immunol. 2015;81(6):483–493. doi:10.1111/sji.12282
   Web of Science ®Google Scholar
• Fillat C, Español T, Oset M, Ferrando M, Estivill X, Volpini V. Identification of WASP mutations in 14 Spanish families with Wiskott-Aldrich syndrome. Am J Med Genet. 2001;100(2):116–121. doi:10.1002/ajmg.1228
   Web of Science ®Google Scholar
• Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980;55(2):243–252. doi:10.1182/blood.V55.2.243.243
   PubMed Web of Science ®Google Scholar
• Gröttum KA, Hovig T, Holmsen H, Abrahamsen AF, Jeremic M, Seip M. Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol. 1969;17(4):373–388. doi:10.1111/j.1365-2141.1969.tb01383.x
   PubMed Web of Science ®Google Scholar
• Baldini MG. Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann N Y Acad Sci. 1972;201(1):437–444. doi:10.1111/j.1749-6632.1972.tb16316.x
   Web of Science ®Google Scholar
• Marathe BM, Prislovsky A, Astrakhan A, Rawlings DJ, Wan JY, Strom TS. Antiplatelet antibodies in WASP (-) mice correlate with evidence of increased in vivo platelet consumption. Exp Hematol. 2009;37(11):1353–1363. doi:10.1016/j.exphem.2009.08.007
   Web of Science ®Google Scholar
• Rivers E, Worth A, Thrasher AJ, Burns SO. How I manage patients with Wiskott Aldrich syndrome. Br J Haematol. 2019;185(4):647–655. doi:10.1111/bjh.15831
   Web of Science ®Google Scholar
• Mahlaoui N, Pellier I, Mignot C, et al. Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome. Blood. 2013;121(9):1510–1516. Epub 2012 Dec 20. doi:10.1182/blood-2012-08-448118
   PubMed Web of Science ®Google Scholar
• Johnston SL, Unsworth DJ, Dwight JF, Kennedy CT. Wiskott-Aldrich syndrome, vasculitis and critical aortic dilatation. Acta Paediatr. 2001;90(11):1346–1348. doi:10.1080/080352501317130452
   Web of Science ®Google Scholar
• McCluggage WG, Armstrong DJ, Maxwell RJ, Ellis PK, McCluskey DR. Systemic vasculitis and aneurysm formation in the Wiskott-Aldrich syndrome. J Clin Pathol. 1999;52(5):390–392. doi:10.1136/jcp.52.5.390
   Web of Science ®Google Scholar
• Nozicka Z, Parízková E, Bednárová J, Lichý J. Izolovaná arteritida bazálních mozkových tepen u dítĕte s primární imunodeficiencí podmínĕnou Wiskottovým-Aldrichovým syndromem [Isolated arteritis in the basal cerebral arteries in a child with primary immunodeficiency due to the Wiskott-Aldrich syndrome]. Cesk Patol. 1987;23:215–221. Czech. PMID: 3442841.
   Google Scholar
• Lao YL, Wong SN, Lawton WM. Takayasu’s arteritis associated with Wiskott-Aldrich syndrome. J Paediatr Child Health. 1992;28(5):407–409. doi:10.1111/j.1440-1754.1992.tb02703.x
   Web of Science ®Google Scholar
• Pellier I, Dupuis Girod S, Loisel D, et al. Occurrence of aortic aneurysms in 5 cases of Wiskott-Aldrich syndrome. Pediatrics. 2011;127(2):e498–504. doi:10.1542/peds.2009-2987
   Web of Science ®Google Scholar
• Watson RD, Gershwin ME, Smithwick E, Castles JJ, Ruebner B. Cutaneous T cell lymphoma and leukocytoclastic vasculitis in a long-term survivor of Wiskott-Aldrich syndrome. Ann Allergy. 1985;55:654-7703-5. PMID: 3877477.
   Google Scholar
• Duzova A, Topaloglu R, Sanal O, et al. Henoch-Schönlein purpura in Wiskott-Aldrich syndrome. Pediatr Nephrol. 2001;16(6):500–502. doi:10.1007/s004670100583
   Web of Science ®Google Scholar
• Kawakami C, Miyake M, Tamai H. Kawasaki disease in a patient with Wiskott-Aldrich syndrome: an increase in the platelet count. Int J Hematol. 2003;77(2):199–200. doi:10.1007/BF02983223
   Web of Science ®Google Scholar
• Filipovich AH, Krivit W, Kersey JH, Burke BA. Fatal arteritis as a complication of Wiskott-Aldrich syndrome. J Pediatr. 1979;95(5 Pt 1):742–744. PMID: 490243. doi:10.1016/s0022-3476(79)80726-x
   Web of Science ®Google Scholar
• Longhurst HJ, Taussig D, Haque T, et al. Non-myeloablative bone marrow transplantation in an adult with Wiskott-Aldrich syndrome. Br J Haematol. 2002;116(2):497–499. doi:10.1046/j.1365-2141.2002.03269.x
   Web of Science ®Google Scholar
• Cooper MD, Chae HP, Lowman JT, Krivit W, Good RA. Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med. 1968;44(4):499–513. doi:10.1016/0002-9343(68)90051-x
   PubMed Web of Science ®Google Scholar
• Spitler LE, Wray BB, Mogerman S, Miller JJ 3rd, O’Reilly RJ, Lagios M. Nephropathy in the Wiskott-Aldrich syndrome. Pediatrics. 1980;66:391–398. PMID: 7422429.
   Web of Science ®Google Scholar
• Gutenberger J, Trygstad CW, Stiehm ER, Opitz JM, Thatcher LG, Bloodworth JM Jr. Familial thrombocytopenia, elevated serum IgA levels and renal disease. A report of a kindred. Am J Med. 1970;49(6):729–741. doi:10.1016/s0002-9343(70)80055-9
   Google Scholar
• Webb MC, Andrews PA, Koffman CG, Cameron JS. Renal transplantation in Wiskott-Aldrich syndrome. Transplantation. 1993;56:1585. PMID: 8279047.
   PubMed Web of Science ®Google Scholar
• DeSanto NG, Sessa A, Capodicasa G, et al. IgA glomerulonephritis in Wiskott-Aldrich syndrome. Child Nephrol Urol. 1988–1989;9(1–2):118–120. PMID: 3251617.
   Google Scholar
• Schurman SH, Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol. 2003;15(4):446–453. doi:10.1097/00002281-200307000-00012
   Web of Science ®Google Scholar
• Ohya T, Yanagimachi M, Iwasawa K, et al. Childhood-onset inflammatory bowel diseases associated with mutation of Wiskott-Aldrich syndrome protein gene. World J Gastroenterol. 2017;23(48):8544–8552. doi:10.3748/wjg.v23.i48.8544
   Web of Science ®Google Scholar
• Cannioto Z, Berti I, Martelossi S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168(2):149–155. doi:10.1007/s00431-008-0721-2
   Web of Science ®Google Scholar
• Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 1998;9(1):81–91. doi:10.1016/s1074-7613(00)80590-7
   Web of Science ®Google Scholar
• Biswas A, Shouval DS, Griffith A, et al. WASP-mediated regulation of anti-inflammatory macrophages is IL-10 dependent and is critical for intestinal homeostasis. Nat Commun. 2018;9(1):1779. doi:10.1038/s41467-018-03670-6
   Web of Science ®Google Scholar
• Monteferrante G, Giani M, van den Heuvel M. Systemic lupus erythematosus and Wiskott-Aldrich syndrome in an Italian patient. Lupus. 2009;18(3):273–277. doi:10.1177/0961203308095000
   Web of Science ®Google Scholar
• Adriani M, Aoki J, Horai R, et al. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol. 2007;124(1):41–48. doi:10.1016/j.clim.2007.02.001
   PubMed Web of Science ®Google Scholar
• Crestani E, Volpi S, Candotti F, et al. Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol. 2015;136(5):1401–4.e1-3. doi:10.1016/j.jaci.2015.08.010
   Web of Science ®Google Scholar
• Taylor MD, Sadhukhan S, Kottangada P, et al. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med. 2010;2(37):37ra44. doi:10.1126/scitranslmed.3000813
   PubMed Web of Science ®Google Scholar
• Sallah S, Wan JY, Hanrahan LR. Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia. Clin Cancer Res. 2001;7:791–794. PMID: 11309323.
   PubMed Web of Science ®Google Scholar
• Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;292(7583):1364–1366. doi:10.1016/s0140-6736(68)92672-x
   Google Scholar
• Kapoor N, Kirkpatrick D, Blaese RM, et al. Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. Blood. 1981;57(4):692–696. PMID: 7008865. doi:10.1182/blood.V57.4.692.692
   Web of Science ®Google Scholar
• Ochs HD, Lum LG, Johnson FL, Schiffman G, Wedgwood RJ, Storb R. Bone marrow transplantation in the Wiskott-Aldrich syndrome. Complete hematological and immunological reconstitution. Transplantation. 1982;34(5):284–288. doi:10.1097/00007890-198211000-00009
   Web of Science ®Google Scholar
• Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: Collaborative Study of the international bone marrow transplant registry and the national marrow donor program. Blood. 2001;97(6):1598–1603. doi:10.1182/blood.v97.6.1598
   PubMed Web of Science ®Google Scholar
• Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European society for immunodeficiencies and European group for blood and marrow transplantation. Blood. 2008;111(1):439–445. doi:10.1182/blood-2007-03-076679
   PubMed Web of Science ®Google Scholar
• Mallhi KK, Petrovic A, Ochs HD. Hematopoietic stem cell therapy for Wiskott-Aldrich syndrome: improved outcome and quality of life. J Blood Med. 2021;12:435–447. doi:10.2147/JBM.S232650
   Web of Science ®Google Scholar
• Corash L, Shafer B, Blaese RM. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood. 1985;65(6):1439–1443. PMID: 3995178. doi:10.1182/blood.V65.6.1439.bloodjournal6561439
   Web of Science ®Google Scholar
• Mullen CA, Anderson KD, Blaese RM. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood. 1993;82(10):2961–2966. PMID: 8219187. doi:10.1182/blood.V82.10.2961.2961
   Web of Science ®Google Scholar